451 related articles for article (PubMed ID: 19026455)
21. Llama peripheral B-cell populations producing conventional and heavy chain-only IgG subtypes are phenotypically indistinguishable but immunogenetically distinct.
Henry KA; van Faassen H; Harcus D; Marcil A; Hill JJ; Muyldermans S; MacKenzie CR
Immunogenetics; 2019 Apr; 71(4):307-320. PubMed ID: 30656359
[TBL] [Abstract][Full Text] [Related]
22. Llama single domain antibodies as a tool for molecular mimicry.
Zarebski LM; Urrutia M; Goldbaum FA
J Mol Biol; 2005 Jun; 349(4):814-24. PubMed ID: 15890359
[TBL] [Abstract][Full Text] [Related]
23. High-expression of monoclonal nanobodies used in the preparation of HRP-conjugated second antibody.
Ahmadvand D; Rahbarizadeh F; Vishteh VK
Hybridoma (Larchmt); 2008 Aug; 27(4):269-76. PubMed ID: 18707545
[TBL] [Abstract][Full Text] [Related]
24. Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies.
De Genst E; Silence K; Decanniere K; Conrath K; Loris R; Kinne J; Muyldermans S; Wyns L
Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4586-91. PubMed ID: 16537393
[TBL] [Abstract][Full Text] [Related]
25. Heavy-chain antibodies in Camelidae; a case of evolutionary innovation.
Nguyen VK; Su C; Muyldermans S; van der Loo W
Immunogenetics; 2002 Apr; 54(1):39-47. PubMed ID: 11976790
[TBL] [Abstract][Full Text] [Related]
26. Landscape of variable domain of heavy-chain-only antibody repertoire from alpaca.
Tu Z; Huang X; Fu J; Hu N; Zheng W; Li Y; Zhang Y
Immunology; 2020 Sep; 161(1):53-65. PubMed ID: 32506493
[TBL] [Abstract][Full Text] [Related]
27. Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii.
Payandeh Z; Rasooli I; Mousavi Gargari SL; Rajabi Bazl M; Ebrahimizadeh W
Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):92-8. PubMed ID: 24463583
[TBL] [Abstract][Full Text] [Related]
28. A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines.
Smolarek D; Hattab C; Hassanzadeh-Ghassabeh G; Cochet S; Gutiérrez C; de Brevern AG; Udomsangpetch R; Picot J; Grodecka M; Wasniowska K; Muyldermans S; Colin Y; Le Van Kim C; Czerwinski M; Bertrand O
Cell Mol Life Sci; 2010 Oct; 67(19):3371-87. PubMed ID: 20458517
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a nanobody phage display library constructed from a Brucella-immunised camel.
Abbady AQ; Al-Mariri A; Zarkawi M; Al-Assad A; Muyldermans S
Vet Immunol Immunopathol; 2011 Jul; 142(1-2):49-56. PubMed ID: 21592585
[TBL] [Abstract][Full Text] [Related]
30. A new method to discriminate immunogen-specific heavy-chain homodimer from heterotetramer immunoglobulin G directly in immunized dromedary whole plasma proteins: Western ligand blotting.
Blanc MR; Anouassi A; Abed MA; Canépa S; Labas V; Bruneau G
Vet Immunol Immunopathol; 2009 Feb; 127(3-4):340-9. PubMed ID: 19091427
[TBL] [Abstract][Full Text] [Related]
31. Immunobiological role of llama heavy-chain antibodies against a bacterial beta-lactamase.
Ferrari A; Rodríguez MM; Power P; Weill FS; De Simone EA; Gutkind G; Leoni J
Vet Immunol Immunopathol; 2007 Jun; 117(3-4):173-82. PubMed ID: 17448545
[TBL] [Abstract][Full Text] [Related]
32. The Camel Adaptive Immune Receptors Repertoire as a Singular Example of Structural and Functional Genomics.
Ciccarese S; Burger PA; Ciani E; Castelli V; Linguiti G; Plasil M; Massari S; Horin P; Antonacci R
Front Genet; 2019; 10():997. PubMed ID: 31681428
[TBL] [Abstract][Full Text] [Related]
33. General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold.
Vincke C; Loris R; Saerens D; Martinez-Rodriguez S; Muyldermans S; Conrath K
J Biol Chem; 2009 Jan; 284(5):3273-3284. PubMed ID: 19010777
[TBL] [Abstract][Full Text] [Related]
34. Structural analysis of effector functions related motifs, complement activation and hemagglutinating activities in Lama glama heavy chain antibodies.
Saccodossi N; De Simone EA; Leoni J
Vet Immunol Immunopathol; 2012 Jan; 145(1-2):323-31. PubMed ID: 22197565
[TBL] [Abstract][Full Text] [Related]
35. Development and production of nanobodies specifically against green fluorescence protein.
Fang Z; Cao D; Qiu J
Appl Microbiol Biotechnol; 2020 Jun; 104(11):4837-4848. PubMed ID: 32270250
[TBL] [Abstract][Full Text] [Related]
36. Isolation and characterization of antigen-specific alpaca (Lama pacos) VHH antibodies by biopanning followed by high-throughput sequencing.
Miyazaki N; Kiyose N; Akazawa Y; Takashima M; Hagihara Y; Inoue N; Matsuda T; Ogawa R; Inoue S; Ito Y
J Biochem; 2015 Sep; 158(3):205-15. PubMed ID: 25888581
[TBL] [Abstract][Full Text] [Related]
37. Anti-erythrocyte natural antibody activity in the unconventional 'heavy chain' immunoglobulins of Indian desert camel (Camelus dromedarius).
Sehrawat S; Singh A
Vet Immunol Immunopathol; 2006 Jun; 111(3-4):139-47. PubMed ID: 16413613
[TBL] [Abstract][Full Text] [Related]
38. A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation.
Eden T; Menzel S; Wesolowski J; Bergmann P; Nissen M; Dubberke G; Seyfried F; Albrecht B; Haag F; Koch-Nolte F
Front Immunol; 2017; 8():1989. PubMed ID: 29410663
[TBL] [Abstract][Full Text] [Related]
39. VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI'.
Hmila I; Abdallah R BA; Saerens D; Benlasfar Z; Conrath K; Ayeb ME; Muyldermans S; Bouhaouala-Zahar B
Mol Immunol; 2008 Aug; 45(14):3847-56. PubMed ID: 18614235
[TBL] [Abstract][Full Text] [Related]
40. Isolation and characterization of recombinant variable domain of heavy chain anti-idiotypic antibodies specific to aflatoxin B1.
Wang D; Xu Y; Tu Z; Fu JH; Xiong YH; Feng F; Tao Y; Lei D
Biomed Environ Sci; 2014 Feb; 27(2):118-21. PubMed ID: 24625402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
